ArticleFunctional & integrative genomics2025
EXO1 as a potential biomarker for prognosis, immune infiltration, and immunotherapy in pan-cancer analysis.
Jikang Wang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it